Carmell (CTCX) Competitors $1.92 -0.40 (-17.41%) As of 09/12/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock CTCX vs. CVRX, ELMD, KRMD, CV, MBOT, PDEX, BSGM, LNSR, AVR, and LAKEShould you be buying Carmell stock or one of its competitors? The main competitors of Carmell include CVRx (CVRX), Electromed (ELMD), KORU Medical Systems (KRMD), CapsoVision (CV), Microbot Medical (MBOT), Pro-Dex (PDEX), Biosig Technologies (BSGM), LENSAR (LNSR), Anteris Technologies Global (AVR), and Lakeland Industries (LAKE). These companies are all part of the "medical equipment" industry. Carmell vs. Its Competitors CVRx Electromed KORU Medical Systems CapsoVision Microbot Medical Pro-Dex Biosig Technologies LENSAR Anteris Technologies Global Lakeland Industries CVRx (NASDAQ:CVRX) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk and valuation. Do analysts recommend CVRX or CTCX? CVRx currently has a consensus price target of $14.00, indicating a potential upside of 102.31%. Given CVRx's stronger consensus rating and higher probable upside, analysts plainly believe CVRx is more favorable than Carmell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CVRx 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.86Carmell 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk & volatility, CVRX or CTCX? CVRx has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Carmell has a beta of 0.51, indicating that its stock price is 49% less volatile than the S&P 500. Do insiders and institutionals believe in CVRX or CTCX? 75.3% of CVRx shares are owned by institutional investors. Comparatively, 24.2% of Carmell shares are owned by institutional investors. 18.9% of CVRx shares are owned by insiders. Comparatively, 29.0% of Carmell shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has higher earnings & valuation, CVRX or CTCX? Carmell has lower revenue, but higher earnings than CVRx. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCVRx$51.29M3.53-$59.97M-$2.10-3.30Carmell$32.84K1,219.71-$15.44MN/AN/A Is CVRX or CTCX more profitable? Carmell has a net margin of 0.00% compared to CVRx's net margin of -95.61%. CVRx's return on equity of -79.31% beat Carmell's return on equity.Company Net Margins Return on Equity Return on Assets CVRx-95.61% -79.31% -40.96% Carmell N/A -217.50%-50.22% Does the media favor CVRX or CTCX? In the previous week, CVRx had 1 more articles in the media than Carmell. MarketBeat recorded 2 mentions for CVRx and 1 mentions for Carmell. CVRx's average media sentiment score of 1.56 beat Carmell's score of 0.00 indicating that CVRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Carmell 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryCVRx beats Carmell on 11 of the 15 factors compared between the two stocks. Get Carmell News Delivered to You Automatically Sign up to receive the latest news and ratings for CTCX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CTCX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTCX vs. The Competition Export to ExcelMetricCarmellSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$40.05M$80.74M$5.78B$10.19BDividend YieldN/AN/A5.73%4.61%P/E RatioN/A11.5874.8626.40Price / Sales1,219.7180.44540.53124.73Price / CashN/A18.4125.8129.91Price / Book1.7910.9313.256.28Net Income-$15.44M-$26.48M$3.29B$270.38M7 Day Performance-21.15%-0.15%0.47%2.70%1 Month Performance-18.47%2.34%4.60%5.99%1 Year Performance307.66%70.69%73.42%25.94% Carmell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTCXCarmellN/A$1.92-17.4%N/A+307.7%$40.05M$32.84K0.0014CVRXCVRx2.7347 of 5 stars$7.73-1.5%$14.00+81.1%+0.3%$205.29M$51.29M0.00160News CoveragePositive NewsELMDElectromed3.993 of 5 stars$23.95-3.2%$36.25+51.4%+31.0%$199.96M$64M31.93160News CoverageInsider TradeKRMDKORU Medical Systems2.7078 of 5 stars$4.11-2.6%$4.63+12.5%+56.8%$195.11M$33.65M0.0080Positive NewsCVCapsoVisionN/A$3.65-2.7%$5.50+50.7%N/A$175.40MN/A0.0090Positive NewsGap DownMBOTMicrobot Medical2.3526 of 5 stars$3.75-1.6%$9.00+140.0%+309.1%$173.53MN/A-6.4720Analyst UpgradeGap DownPDEXPro-Dex2.6941 of 5 stars$46.04-1.8%$56.00+21.6%+23.9%$152.88M$53.84M16.74140News CoverageBSGMBiosig Technologies2.0399 of 5 stars$4.73-1.0%$10.00+111.4%+1,316.9%$150.18M$40K0.0050Gap DownLNSRLENSAR1.5936 of 5 stars$12.35+0.6%$15.00+21.5%+146.4%$146.56M$53.49M0.00110News CoveragePositive NewsAVRAnteris Technologies Global1.7032 of 5 stars$4.11+2.2%$16.50+301.5%N/A$144.97M$2.70M0.00138Positive NewsLAKELakeland Industries4.863 of 5 stars$15.14-0.3%$26.00+71.7%-28.7%$144.53M$167.21M-5.032,100News CoverageEarnings ReportAnalyst UpgradeShort Interest ↓Analyst Revision Related Companies and Tools Related Companies CVRX Alternatives ELMD Alternatives KRMD Alternatives CV Alternatives MBOT Alternatives PDEX Alternatives BSGM Alternatives LNSR Alternatives AVR Alternatives LAKE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CTCX) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carmell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carmell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTCX Stock Alerts